Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Meningococcal disease
2021
2011
Americas
Clear all
Type of publications
NITAG documentation
(64)
Systematic reviews (SYSVAC)
(4)
Topics
Available to download in languages
Regions
Americas
(68)
Africa
(17)
Europe
(77)
South-East Asia
(2)
Western Pacific
(14)
Countries
Argentina
(1)
Bolivia
(2)
Canada
(16)
Chile
(9)
United States of America
(40)
Diseases
COVID-19
(64)
Meningococcal disease
(4)
Diphtheria
(3)
Ebola
(1)
Haemophilus influenzae type B
(1)
Hepatitis B
(1)
Human papillomavirus (HPV)
(5)
Influenza
(2)
Japanese encephalitis
(2)
Rotavirus
(3)
Varicella
(1)
Vaccine topics
Acceptance
(1)
Coverage
(1)
Ethical issues
(2)
Safety
(1)
Target population
Adults
(2)
All age groups
(3)
Children
(3)
Healthcare workers
(1)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(5)
Publication date
2021
(65)
2011
(3)
2024
(1)
2023
(12)
2022
(42)
2020
(63)
2019
(6)
2018
(3)
2017
(3)
2016
(12)
2015
(5)
2014
(5)
2013
(3)
2010
(1)
2009
(1)
2008
(1)
2007
(2)
2006
(3)
2005
(1)
1997
(1)
68 results found
2021
∙
NACI
Recommendations on the use of COVID-19 Vaccines
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine
2021
∙
ACIP
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update of ACIP - 9 July 2021
2011
∙
ACIP
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease
2011
∙
ACIP
Updated Recommendations for Use of Meningococcal Conjugate Vaccines
2011
∙
ACIP
Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register